retatrutide phase 2 nejm weight loss 48 weeks triple agonist Delivers 22.6% in TRIUMPH-2 and TRIUMPH-3 Trials | Kh Mahfuz Ullah posted on the topic Retatrutide's July 23 Phase 3

For many people, the path to sustainable weight loss no longer involves extreme dieting or high-intensity workouts aloneit now includes scientifically backed therapies like GLP-1 medications

Sources TRICARE pharmacy coverage for Wegovy, Ozempic, Mounjaro: TRICARE coverage for weight-loss medication (GoodRx): TRICARE coverage for Wegovy and Zepbound 2026 (PEAK): TRICARE limits on GLP-1 for certain groups: CHAMPVA covered medications (VA Meds by Mail): Getting care through CHAMPVA: STEP and SURMOUNT trial data: auto-rendered in the page citation panel See your options in about 2 minutes Take the free quiz and see what fits you

This matches nearly 500 million individuals, a figure that increased by 48% from 1990 to 2019 in the world [4, 5]

S.CaoY.KoT

Seek emergency care immediately (call 911 or go to the nearest emergency department) for: Severe, sudden abdominal pain with inability to pass gas or stool (possible obstruction) Vomiting fecal-material or persistent bilious vomiting Signs of severe dehydration (dizziness, decreased urination, confusion) Your provider may need to perform a physical examination, review your medication regimen, and potentially order investigations such as abdominal imaging if complications are suspected

In 2017, the FDA approved the drug to treat type 2 diabetes under the brand name Ozempic